The Asia Pacific Bioprocess Validation Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).
The bioprocess can be explained as a process that utilizes complete living cells or cellular components to get the desired items. The process is used to create nourishments, flavors, energy, pharmaceuticals, and synthetic concoctions with the guidance of a biocatalyst. A catalyst in bioprocessing can be plants, microorganisms or creature cells in a bioreactor. It includes hereditary designing to control animals, microorganisms, and plants.
Downstream handling is required to expel debasements, decrease mass volume, and concurrent convergence of the ideal item from the bioreactor. Bioprocessing is also essential to producing renewable biofuels like ethanol and biodiesel, therapeutics stem cells, gene therapy vectors and new vaccines, among other emerging technologies and industries. Bioprocessing contains two essential processes which are upstream and downstream processes.
Cell treatment bioprocessing is an order that joins the fields of bioprocessing and cell treatment. Cell treatment bioprocessing aims to build up reproducible and sturdy manufacturing procedures to create remedial cells. Commercially significant bioprocesses can generate items to keep up the quality gauges of biopharmaceutical drugs. It can offer clinical and industrial remedial cell measures through different enhancement phases. It also controls the expense of merchandise of the last medication item.
India is ranked amongst the top biotech destinations globally. The Indian biotech industry is likely to see significant growth due to the rising economic prosperity, health consciousness, and population of more than a billion. The biotech industry is estimated to be around $63 billion in 2019-20 and is expected to grow to $150 billion by 2025. The Indian biotechnology industry comprises of around 3500 biotech start-ups and is estimated to reach 10,000 by 2024-25. Vaccines and recombinant therapeutics drive the biotechnology industry’s growth in India.
The China market dominated the Asia Pacific Bioprocess Validation Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $53.2 Million by 2028. The Japan market is estimated to grow a CAGR of 8.7% during (2022 - 2028). Additionally, The India market would experience a CAGR of 10.1% during (2022 - 2028).
Based on Stage, the market is segmented into Continued Process Verification, Process Qualification, and Process Design. Based on Mode, the market is segmented into In House and Outsourced. Based on Testing Type, the market is segmented into Bioprocess Residuals Testing, Extractables & Leachables Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Sartorius AG, Merck KGaA, Lonza Group AG, Danaher Corporation, Charles River Laboratories International, Inc., SGS S.A., Labcorp Corporation, and Cobetter Filtration equipment Co., Ltd.
The bioprocess can be explained as a process that utilizes complete living cells or cellular components to get the desired items. The process is used to create nourishments, flavors, energy, pharmaceuticals, and synthetic concoctions with the guidance of a biocatalyst. A catalyst in bioprocessing can be plants, microorganisms or creature cells in a bioreactor. It includes hereditary designing to control animals, microorganisms, and plants.
Downstream handling is required to expel debasements, decrease mass volume, and concurrent convergence of the ideal item from the bioreactor. Bioprocessing is also essential to producing renewable biofuels like ethanol and biodiesel, therapeutics stem cells, gene therapy vectors and new vaccines, among other emerging technologies and industries. Bioprocessing contains two essential processes which are upstream and downstream processes.
Cell treatment bioprocessing is an order that joins the fields of bioprocessing and cell treatment. Cell treatment bioprocessing aims to build up reproducible and sturdy manufacturing procedures to create remedial cells. Commercially significant bioprocesses can generate items to keep up the quality gauges of biopharmaceutical drugs. It can offer clinical and industrial remedial cell measures through different enhancement phases. It also controls the expense of merchandise of the last medication item.
India is ranked amongst the top biotech destinations globally. The Indian biotech industry is likely to see significant growth due to the rising economic prosperity, health consciousness, and population of more than a billion. The biotech industry is estimated to be around $63 billion in 2019-20 and is expected to grow to $150 billion by 2025. The Indian biotechnology industry comprises of around 3500 biotech start-ups and is estimated to reach 10,000 by 2024-25. Vaccines and recombinant therapeutics drive the biotechnology industry’s growth in India.
The China market dominated the Asia Pacific Bioprocess Validation Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $53.2 Million by 2028. The Japan market is estimated to grow a CAGR of 8.7% during (2022 - 2028). Additionally, The India market would experience a CAGR of 10.1% during (2022 - 2028).
Based on Stage, the market is segmented into Continued Process Verification, Process Qualification, and Process Design. Based on Mode, the market is segmented into In House and Outsourced. Based on Testing Type, the market is segmented into Bioprocess Residuals Testing, Extractables & Leachables Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Sartorius AG, Merck KGaA, Lonza Group AG, Danaher Corporation, Charles River Laboratories International, Inc., SGS S.A., Labcorp Corporation, and Cobetter Filtration equipment Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Stage
- Continued Process Verification
- Process Qualification
- Process Design
By Mode
- In House
- Outsourced
By Testing Type
- Bioprocess Residuals Testing
- Extractables & Leachables Testing
- Viral Clearance Testing
- Filtration & Fermentation Systems Testing
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc
- Eurofins Scientific SE
- Sartorius AG
- Merck KGaA
- Lonza Group AG
- Danaher Corporation
- Charles River Laboratories International, Inc
- SGS S.A
- Labcorp Corporation
- Cobetter Filtration equipment Co., Ltd
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Bioprocess Validation Market, by Stage
1.4.2 Asia Pacific Bioprocess Validation Market, by Mode
1.4.3 Asia Pacific Bioprocess Validation Market, by Testing Type
1.4.4 Asia Pacific Bioprocess Validation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Bioprocess Validation Market
Chapter 4. Asia Pacific Bioprocess Validation Market by Stage
4.1 Asia Pacific Continued Process Verification Market by Country
4.2 Asia Pacific Process Qualification Market by Country
4.3 Asia Pacific Process Design Market by Country
Chapter 5. Asia Pacific Bioprocess Validation Market by Mode
5.1 Asia Pacific In House Market by Country
5.2 Asia Pacific Outsourced Market by Country
Chapter 6. Asia Pacific Bioprocess Validation Market by Testing Type
6.1 Asia Pacific Bioprocess Residuals Testing Market by Country
6.2 Asia Pacific Extractables & Leachables Testing Market by Country
6.3 Asia Pacific Viral Clearance Testing Market by Country
6.4 Asia Pacific Filtration & Fermentation Systems Testing Market by Country
6.5 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Bioprocess Validation Market by Country
7.1 China Bioprocess Validation Market
7.1.1 China Bioprocess Validation Market by Stage
7.1.2 China Bioprocess Validation Market by Mode
7.1.3 China Bioprocess Validation Market by Testing Type
7.2 Japan Bioprocess Validation Market
7.2.1 Japan Bioprocess Validation Market by Stage
7.2.2 Japan Bioprocess Validation Market by Mode
7.2.3 Japan Bioprocess Validation Market by Testing Type
7.3 India Bioprocess Validation Market
7.3.1 India Bioprocess Validation Market by Stage
7.3.2 India Bioprocess Validation Market by Mode
7.3.3 India Bioprocess Validation Market by Testing Type
7.4 South Korea Bioprocess Validation Market
7.4.1 South Korea Bioprocess Validation Market by Stage
7.4.2 South Korea Bioprocess Validation Market by Mode
7.4.3 South Korea Bioprocess Validation Market by Testing Type
7.5 Singapore Bioprocess Validation Market
7.5.1 Singapore Bioprocess Validation Market by Stage
7.5.2 Singapore Bioprocess Validation Market by Mode
7.5.3 Singapore Bioprocess Validation Market by Testing Type
7.6 Malaysia Bioprocess Validation Market
7.6.1 Malaysia Bioprocess Validation Market by Stage
7.6.2 Malaysia Bioprocess Validation Market by Mode
7.6.3 Malaysia Bioprocess Validation Market by Testing Type
7.7 Rest of Asia Pacific Bioprocess Validation Market
7.7.1 Rest of Asia Pacific Bioprocess Validation Market by Stage
7.7.2 Rest of Asia Pacific Bioprocess Validation Market by Mode
7.7.3 Rest of Asia Pacific Bioprocess Validation Market by Testing Type
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Geographical Expansions:
8.1.6 SWOT Analysis
8.2 Eurofins Scientific SE
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Acquisition and Mergers:
8.3 Sartorius AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Merck KGaA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.5 Lonza Group AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Charles River Laboratories International, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.8 SGS S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.9 Labcorp Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.10. Cobetter Filtration equipment Co., Ltd.
8.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Sartorius AG
- Merck KGaA
- Lonza Group AG
- Danaher Corporation
- Charles River Laboratories International, Inc.
- SGS S.A.
- Labcorp Corporation
- Cobetter Filtration equipment Co., Ltd.
Methodology
LOADING...
